All export restrictions on ventilators have now been removed and 'Make in India' ventilators are being exported. The year witnessed tremendous achievements in the medical supplies sector in the country, the ministry said.
"At the beginning of the pandemic, India was almost totally dependent on imported ventilators, PPE kits and N-95 masks," it said. "There were, in fact, no standard specifications for these products which are essential in the fight against the pandemic."
The central government recognised the challenges posed by the pandemic in the very initial stages and successfully ensured more than adequate availability and supplies of essential medical items across the country, according to the ministry.
In the case of personal protective equipment (PPE), India has now become the world's second-largest manufacturer from a miniscule domestic production capacity in March. There is a production capacity of more than 10 lakh PPE coveralls per day and it is also exported to several countries, the ministry said.
There are already nearly 1,700 indigenous manufacturers and suppliers registered on the government e-marketplace, with dozens already certified by the Bureau of Indian Standards.
Nearly 1.7 crore lakh PPE kits have been distributed free of cost to the states, Union territories and central institutions.
"The buffer stock of PPE kits available with the central and state governments has grown from about 2 lakh in March to more than 89 lakh at present. The average price has come down substantially from nearly Rs 600 to about Rs 200 per kit in 9 months," the ministry said.
There were only three suppliers of N-95 masks with a production capacity of less than 1 lakh masks per day. Now over 3,000 manufacturers and suppliers, including 1,509 BIS-certified ones, of N-95 masks are already registered on the government portal and the domestic production capacity has risen to more than 8 lakh per day, it said.
These are also being exported from India in large quantities. More than 4 crore N-95 masks have so far been distributed free of cost to various states, Union territories and central institutions.
The buffer stock of N-95 masks available with the central and state governments has risen sharply from about 9 lakh in March to about 1.46 crore at present and the average prices have dropped from about Rs 40 to Rs 12 per mask during the same period,the ministry stated.
The government has already placed orders for procurement of nearly 83 crore syringes. Additionally, bids have also been invited for nearly 35 crore syringes. These will be used for COVID vaccination and also for the universal immunisation programme.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.